ABSTRACT: To study the antigenic nature of the glycoprotein (G protein) of infectious hematopoietic necrosis virus (IHNV), 31 neutralizing monoclonal antibodies (MAbs) were produced against a reference isolate of the virus. The MAbs were compared using a neutralization assay, an enzyme-linked immunosorbent assay (ELISA), and by immunoblotting of the G protein in the native, reduced, and deglycosylated forms. Hybridoma culture fluids of the various MAbs could be diluted from 1:2 to 1:512 and still completely neutralize 1 X 104 plaque-forming units of IHNV. Similarly, the end point dilutions that produced optical density readings of 0.1 or greater in the ELISA were 1:40 to 1:10240. Western blotting showed that all of the MAbs reacted with the G protein in the unreduced (i.e. native) conformation; however, only 9 nine of the MAbs were able to react with the G protein following reduction by 2-mercaptoethanol. Deglycosylation of the protein did not influence the binding ability of any of the MAbs. These data indicate that all the MAbs recognized amino acid sequences on the protein itself and that the IHNV glycoprotein contains linear as well as conformation-dependent neutralizing epitopes. When rainbow trout Oncorhynchus mykiss fingerlings were passively immunized with MAbs against either a linear or a conformation-dependent epitope, the fish were protected against challenge with wild-type IHNV.
INTRODUCTION
Infectious hematopoietic necrosis virus (IHNV) is a fish rhabdovirus that produces an acute disease (IHN) resulting in destruction of the hematopoietic tissues of the kidney and spleen and in the loss of millions of salmon and trout each year (Wolf 1988) . Because IHN is untreatable, control methods have relied on prevention by improved water quality, disinfection of eggs, sanitation of fish culture facilities, and destruction of infected fish populations (Winton 1991) .
Several vaccines have been developed and tested for controlling IHN, including killed and attenuated preparations ). Engelking & Leong (1989) showed that the IHNV glycoprotein (G protein) alone ' Addressee for correspondence O Inter- Research 1994 was able to induce neutralizing antibodies in rabbits and to immunize salmonids against challenge with the virus. The newest vaccines against IHNV are subunit vaccines developed by cloning regions of the glycoprotein gene of IHNV into Escherichia coli (Gilmore et al. 1988 , Xu et al. 1991 or baculovirus (Koener & Leong 1990 ) expression systems. Laboratory and field trials showed that a subunit vaccine could stimulate protective immunity in trout against IHNV (Leong et al. 1992) . Similarly, the glycoprotein of viral hemorrhagic septicemia virus (VHSV) expressed in Escherichia col1 was shown to be immunogenic in trout (Lorenzen et al. 1993) .
Monoclonal antibodies (MAbs) have been useful in the study of rhabdovirus glycoprotein structure and function and in defining neutralizing epitopes on rabies virus (Lafon et al. 1983 , Benmansour et al. 1991 and vesicular stomatitis virus (VSV; Lefrancois & Lyles 1982 , Luo et al. 1988 . Among fish rhabdoviruses, neutralizing MAbs have been developed against isolates of IHNV , Ristow & Arnzen de Avila 1991 and VHSV (Lorenzen et al. 1988 (Lorenzen et al. , 1990 . In addition to serving as reagents for determining the antigenic diversity among field isolates of IHNV, these MAbs have been used to select variants of the virus that were attenuated in virulence (Roberti et al. 1991) , to develop a preliminary epitope map of the IHNV glycoprotein (Xu et al. 1991) , and to passively protect fish against VHSV (Lorenzen et al. 1990 ).
The purpose of this research was to produce a large panel of MAbs against a single reference isolate of IHNV that would recognize the various neutralizing epitopes on the viral glycoprotein to further characterizc thc net-re cf these sntigsnic deterrr?inants.
MATERIALS AND METHODS
Cells and virus. Chinook salmon embryo (CHSE-214) cells (Lannan et al. 1984) were maintained in minimum essential medium (MEM, Gibco BRL, Grand isiand, NY, USA) supplen~ented with 10 O / i fetal bovine serum (Gibco), 2 mM L-glutamine (Gibco), 0.3 % tryptose phosphate broth (Difco Lab., Detroit, MI, USA), 100 IU ml-' penicillin, 100 pg ml-' streptomycin, and 100 pg ml-' gentamicin sulphate (U.S. Biochem. Corp., Cleveland, OH, USA) at pH 7.5. For the neutralization assay, we used epithelioma papulosum cyprini (EPC) cells (Fijan et al. 1983) .
We used the Western Regional Aquaculture Center (WRAC) reference isolate of IHNV recovered in 1982 from rainbow trout fry at a commercial facility in the Hagerman Valley, ID, USA. Monolayer cultures of CHSE-214 cells were infected with IHNV at a multiplicity of infection of 0.001 plaque-forming units (PFU) per cell and incubated at 15 "C for 7 d. Culture supernatant was harvested and centrifuged at 10000 X g for 20 min at 4 "C to remove the cell debris. Viral purification was performed on discontinuous and continuous sucrose gradients according to the procedures described by Hsu et al. (1986) and Kurath & Leong (1985) .
Production of hybridomas and monoclonal antibodies. Adult female BALB/c mice were immunized by intraperitoneal injection with 0.5 m1 of a mixture of purified IHNV and an equal volume of Freund's complete adjuvant. A similar inoculation was given 3 wk later using Freund's incomplete adjuvant. After an additional 4 wk, the immunized mice received a final booster by intravenous injection in the tail vein with 0.2 m1 of diluted IHNV antigen without adjuvant. The fusion was carried out 3 d after the final injection using methods described by Mishell & Shiigi (1980) and Lane (1985) . Briefly, fusion between IHNV-immunized spleen cells and SP2/0 Ag-l4 myeloma cells was induced with 50 % polyethylene glycol l500 and 4000 (4:l). Hybridomas secreting IHNV-specific neutralizing antibody were selected by a micro-neutralization assay ) and positive clones were subcloned twice by limiting dilution and then expanded in culture flasks for in vitro production of antibody. MAb class and subclass were determined by enzyme-linked immunosorbent assay (ELISA) using mouse sub-isotyping kit (Bio-Rad Laboratories, Richmond, CA, USA).
Neutralization assay. Neutralizing antibody titers were determined by a modification of the method of Rovozzo & Burke (1973) . Briefly, serial 2-fold dilutions of the hybridoma fluids were prepared in 96-well m i c r o t l t~r plates with MEM and reacted with equal volumes of a suspension containing 1 X 104 PFU ml-' of IHNV. After 1 h incubation at 15 "C, titrations were performed using monolayers of EPC cells. The neutralization titer was expressed as the last dilution of the hybridoma culture supernatant completely neutralizing all the input virus in the well.
Enzyme-linked immunosorbent assay. Ninety-six well, !mmulcn I MicroElisa plates (Dynatech Lab., Alexandria, VA, USA) were coated with 0.5 pg of purified IHNV per well in carbonate buffer, pH 9.6, and allowed to incubate overnight at 4 "C. Plates were washed 3 times with phosphate buffered saline (PBS) containing 0.05 % Tween 20 (PBST), and then 50 p1 of test hybridoma supernatant was added. After 2 h incubation at room temperature (RT), the plates were washed 3 times with PBST. Next, 50 p1 of diluted horseradish peroxidase (HRP)-conjugated goat anti-mouse irnmunoglobulin (Ig) (Hyclone Laboratories, Logan, UT, USA) was added to each well, and the plates were incubated for 60 min at RT. After 5 washes, the chromogen, consisting of 1 mM ABTS [2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)] and 0.03 % hydrogen peroxide (H,02) in 0.1 M sodium citrate buffer, pH 4.2, was added and allowed to react for 30 min at RT The absorbance of the samples was monitored at 405 nm in a microplate reader (Bio-Tek Instruments, Winooski, VT, USA), and the ELISA titer was expressed as the last dilution of the hybridoma culture supernatant that produced an optical density (OD) reading equal to or greater than 0.1 OD units.
Preparation of samples for electrophoresis. The structural proteins of IHNV were separated by electrophoresis under either reducing or non-reducing conditions. The viral glycoprotein was deglycosylated by means of an enzyme preparation containing equal activities of endoglycosidase F and glycopeptidase F (ENDO-F; Sigma Chemical Co., St. Louis, MO, USA; Plurnrner et al. 1984) . Purified virus (50 pg ml-l) was incubated overnight at 37 "C with 2 units ml-' of 
All k light chains Neutralizing titers are expressed as the last dilution of the hybridoma culture supernatant completely neutralizing an equal volume of a suspension containing 1 X 104 PFU ml-' of IHNV C ELISA titers are expressed as the last dilution that provided an absorbance reading 2 0.1 RESULTS ENDO-F in 15 % sucrose, 150 mM NaC1,lO mM EDTA, blocked by incubation in 5 %bovine serum albumin for 10 mM NaH2P04, pH 7.5, and 0.025 % (w/v) sodium 60 min at 37 "C. The nitrocellulose sheets were cut into dodecyl sulfate (SDS) solution. Samples were subsestrips and reacted with individual MAbs followed by quently mixed with gel loading solution containing 3 % incubation with HRP-conjugated goat anti-mouse Ig glycerol, 1 % SDS, and 30 FM bromophenol blue. In (Hyclone). After washing the strips, the reactions were samples to be run under reducing conditions, 25 pM visualized by color development with a substrate solu-2-mercaptoethanol was included in the solution. All tion composed of 10 m1 of 0.3 % 4-chloro-l-napthol the samples were boiled for 3 min and then subjected (Bio-Rad) in methanol and 50 m1 of 0.03 % H 2 0 2 in PBS. to electrophoresis.
Purification of immunoglobulin. MAbs in culture Electrophoresis and immunoblotting. Ten percent supernatants were concentrated about 50-fold by prepolyacrylamide gels containing SDS were run accordcipitation with 50 % (NH4)2S04. This concentrate was ing to the method of Laemmli (1970) and transferred by dialyzed against PBS and then purified by affinity electroblotting onto nitrocellulose sheets (Schleicher & chromatography using protein A-Sepharose 4B Schuell, Keene, NH, USA), as described by Towbin et (Pharmacia Biotech, Piscataway, NJ, USA) according al. (1979) . Excess binding sites on the membranes were to the procedure described by Ey et al. (1978) . The eluate was then concentrated with Thirty-one hybridomas that produced useful levels of neutralizing antibodies against IHNV were selected Passive immunization. To determine if selected MAbs could provide passive protection to rainbow trout, we injected MAbs directed against conformation-dependent (MAb 1H8) and linear (MAb 6A7) epitopes. Two hundred juvenile rainbow trout (2 g) were anaesthetized with benzocaine (35 mg 1-l) and given a n intraperitoneal injection with 50 pg of purified MAb in 50 p1 PBS or with 50 p1 PBS only. After a 2 h recovery period, duplicate groups of 25 fish that were injected with each of the MAbs and a duplicate group of controls that was injected with PBS were challenged by 1 h bath exposure to 1 X 105 PFU ml-' of wild-type IHNV. A fourth group of duplicate aquaria contained fish injected with PBS but not challenged with IHNV. Fish were maintained in flowing water at 12 "C in aquaria containing 5 1 of water. Dead fish were collected daily and examined for visible signs of disease. After 4 wk, the percentage of survivors was calculated and the data tested for significance by chi-square analysis. a n d cloned (Table 1 ) . Culture fluids from the 31 hy-IHNV. The end-point dilutions to produce a n OD readbridomas could be diluted between 1:2 and 1:512 and ing of 0.1 or gr-eater in the ELISA ranged from 1:40 to still completely neutralize infectivity in a n equal vol- 
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The specificity of each MAb for the reduced, unreduced, and deglycosylated forms of the IHNV glycoprotein was determined by immunoblotting. All of the MAbs reacted with the G protein in the unreduced (native) conformation and
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MAbs i H 1 2 , 2Fi12, 2D3, 3B12, 4 E i 0 , 5 A 6 , 6A7, 6H7, and 6A12 were able to ) th.e native conformation following deglycosylation. Strips 1 to 12 were developed using cell culture flutds containing MAbs 1 E l l , 1H8, 1H10, 2C5, 2E9, 3F12, 3H12, 5A6, 5G3, 6A7, 6D7 and 6H7, respect~vely. Strip 13 was developed usi.ng culture fluid from SP2 myeloma cultures as a control. The positions of the IHNV glycoprotein in the n a t~v e (G) and deglycosylated (Deg.-G) forms are shown bind to the G protein after reduction of disulfide bonds indicating these nine MAbs were directed at linear deterrninants on the molecule ( Table 1) . Treatment of the purified virus with ENDO-F prior to electrophoresis and blotting did not affect the ability of any of the MAbs to bind to the G protein (Fig.  1 ) . As expected, the removal of carbohydrates reduced the molecular weight of the G protein and sharpened the bands (Fig. 1) . None of the MAbs reacted with other structural proteins of the virus.
Passive protection of fish
MAbs 1H8 and 6A7 were concentrated and purified from culture supernatants in order to determine the protective ability of these preformed neutralizing antibodies in fish. Both MAbs conferred a significant degree of protection against waterborne challenge (Table 2 ). The duplicate group of 25 fish that received MAb 1H8 averaged 98 % survivors and the duplicate group receiving MAb 6A7 averaged 94 % survivors. These results were similar to the average survival of fish in the control group injected with PBS but not "Each group included 2 aquaria with 25 fish in each 'Each fish was injected w~t h 50 p1 of PBS or 50 p1 PBS containing MAb (1 pg p1-') 'Fish were challenged by 1 h waterborne exposure to 1 X 10' PFU ml-l of wild-type IHNV d~a l u e s represent average of 2 aquaria challenged with IHNV (94 %) and significantly greater (p < 0.001) than the average survival among fish in the control group which were challenged with the virus (46 %).
DISCUSSION
In this study, a panel of neutralizing MAbs was produced against a single isolate of IHNV. All the MAbs reacted specifically with the viral glycoprotein, extending the results of Engelking & Leong (1989) , who showed that purified IHNV glycoprotein stimulated neutralizing antibody in rabbits and a protective response in fish. Likewise, in rabies virus and VSV, neutralizing MAbs have been shown to be directed against the glycoprotein, and protection was induced by purified G protein (Lefrancois & Lyles 1982 , Lafon et al. 1983 .
For investigation of the role of disulfide bonds and tertiary structure of the glycoprotein on the ability of neutralizing antibodies to bind to epitopes, the IHNV glycoprotein was reduced by including 2-mercaptoethanol in the electrophoresis sample buffer. Because all MAbs reacted with the IHNV glycoprotein in the unreduced state, but only 9 of the MAbs recognized the protein following reduction of disulfide bonds, we believe that the IHNV glycoprotein contains linear as well as conformational (disulfide bond-dependent) neutralizing epitopes.
In addition to determining the presence of linear neutralizing epitopes, we wanted to know if carbohydrate moieties were integrated into the neutralizing epitopes reacting with these MAbs. Because N-linked oligosaccharide chains represent the only known type of carbohydrate in rhabdovirus glycoprotein (DuboisDalcq et al. 1984) , and because Engelking & Leong (1989) reported that N-linked, but not 0-linked, oligosaccharides were present on the IHNV G protein, we removed the N-linked carbohydrate groups of the protein by ENDO-F (Plummer et al. 1984) . Deglycosylation of the IHNV antigen did not abolish the binding ability of any of these MAbs, confirming that these neutralizing MAbs are specific to the G protein structure and recognize carbohydrate-free epitopes. Analogous results have been reported for the glycoprotein of VHSV (Lorenzen et al. 1990 ). However, glycosylation is known to influence protein folding (Hongo et al. 1986 ). In the case of VSV, such G protein glycosylation has been found to be essential for the correct formation of disulfide bonds, as well as for intracellular transport (Machamer & Rose 1988 , Grigera et al. 1991 ). The precise role of N-Linked glycosylation in the IHNV glycoprotein remains to be investigated.
The linear neutralizing epitopes on the IHNV glycoprotein identified by certain of our MAbs probably represent those epitopes stimulating neutralizing antibodies in fish vaccinated by recombinant IHNV and VHSV glycoproteins expressed in Eschenchia coli because these recombinant proteins would be neither glycosylated nor folded into the native structure. The presence of 1 or more linear epitopes indicates that a synthetic peptide may also stimulate protective immunity against the disease. A synthetic peptide resembling the structure of a linear, virus-neutralizing epitope of the rabies virus glycoprotein has been demonstrated to be capable of inducing G proteinspecific neutralizing antibody in vivo (Dietzschold et al. 1990 ). The use of synthetic peptides representing selected amino acid sequences from the IHNV G protein may offer an alternative approach for development of an effective vaccine.
The protective ability of 2 of our neutralizing MAbs was demonstrated by passive immunization of rainbow trout. Both MAb 1H8, which recognized a conformation-dependent epitope, and MAb 6A7, which recognized a linear epitope, conferred significant protection against waterborne challenge. This result indicates that if neutralizing antibodies could be induced in fish by a synthetic peptide vaccine that contains the amino acid sequence of the linear epitope, such antibodies might have a protective effect in vivo.
The MAbs developed in this project have also served as useful diagnostic reagents for confirmation of IHNV. Although they do not recognize all isolates of the virus (Scott LaPatra, Clear Springs Trout Company, ID, USA; Ted Meyers, Alaska Department of Fish and Game, unpubl. data), they are consistent reagents that can be produced in large quantities with little effort or expense. These antibodies have also found an important application in epidemiological studies of IHNV and in examining the antigenic diversity among isolates of IHNV within commercial trout facilities (S. LaPatra unpubl. obs.).
Our results provide new information about the nature of the epitopes on the IHNV glycoprotein that stimulate neutralizing antibodies. In addition, the MAbs developed in this study will serve as useful tools for more precisely locating these epitopes by sequencing the G protein of IHNV mutants that escape neutralization. More detailed knowledge of the IHNV neutralizing epitope structure will aid in the design of IHN vaccines, whlch are needed for control of this disease in aquaculture.
